Therapeutic Group: Oncology Presentation Imacent 100: Each tablet contains Imatinib Mesylate INN equivalent to Imatinib 100 mg. Imacent 400: Each tablet contains Imatinib Mesylate INN equivalent to Imatinib 400 mg. Description Imatinib mesylate is a protein-tyrosine kinase inhibitor that inhibits the BCR-ABL tyrosine kinase; the constitutive abnormal tyrosine kinase created by the Philadelphia chromosome abnormality […]